LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 48 filers reported holding LOGICBIO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,000 | -62.5% | 9,848 | -53.7% | 0.00% | – |
| Q2 2022 | $8,000 | -52.9% | 21,276 | +181.4% | 0.00% | – |
| Q4 2021 | $17,000 | -94.1% | 7,561 | -87.9% | 0.00% | – |
| Q3 2021 | $286,000 | -1.0% | 62,493 | -4.0% | 0.00% | – |
| Q2 2021 | $289,000 | +932.1% | 65,094 | +1594.7% | 0.00% | – |
| Q1 2021 | $28,000 | +21.7% | 3,841 | +24.9% | 0.00% | – |
| Q4 2020 | $23,000 | +2200.0% | 3,075 | +2080.9% | 0.00% | – |
| Q3 2020 | $1,000 | -97.0% | 141 | -96.4% | 0.00% | – |
| Q2 2020 | $33,000 | +37.5% | 3,878 | -20.0% | 0.00% | – |
| Q1 2020 | $24,000 | -67.6% | 4,847 | -53.1% | 0.00% | – |
| Q4 2019 | $74,000 | +7.2% | 10,333 | +63.0% | 0.00% | – |
| Q3 2019 | $69,000 | +245.0% | 6,340 | +322.4% | 0.00% | – |
| Q2 2019 | $20,000 | – | 1,501 | +3093.6% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 47 | -98.4% | 0.00% | – |
| Q4 2018 | $31,000 | – | 3,003 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 500,000 | $2,220,000 | 0.38% |
| Orbimed Advisors | 8,466,783 | $37,593,000 | 0.38% |
| Sio Capital Management, LLC | 182,630 | $811,000 | 0.20% |
| Tibra Equities Europe Ltd | 76,500 | $340,000 | 0.10% |
| SAMLYN CAPITAL, LLC | 1,420,452 | $6,308,000 | 0.09% |
| PURA VIDA INVESTMENTS, LLC | 249,256 | $1,107,000 | 0.03% |
| Trexquant Investment LP | 46,229 | $205,000 | 0.02% |
| SANDERS MORRIS HARRIS LLC | 15,000 | $67,000 | 0.01% |
| Baker Brothers Advisors | 451,478 | $2,005,000 | 0.01% |
| Verition Fund Management LLC | 208,099 | $924,000 | 0.01% |